Warenkorb
€ 0,00 0 Buch dabei,
portofrei
Management of Comorbidities in Kidney Disease in the 21st Century: Anemia, Bone Disease, Malnutrition, and Inflammation als Buch
- 7 % **

Management of Comorbidities in Kidney Disease in the 21st Century: Anemia, Bone Disease, Malnutrition, and…

Sprache: Englisch.
Buch (gebunden)
Ihr 12%-Rabatt auf alle Spielwaren, Hörbücher, Filme, Musik u.v.m
 
12% Rabatt sichern mit Gutscheincode: SONNE12
 
Jetzt

155,99*

inkl. MwSt.
Bisher: € 167,99
Portofrei
vorbestellbar
Management of Comorbidities in Kidney Disease in the 21st Century: Anemia, Bone Disease, Malnutrition, and Inflammation als Buch

Produktdetails

Titel: Management of Comorbidities in Kidney Disease in the 21st Century: Anemia, Bone Disease, Malnutrition, and Inflammation

ISBN: 1405104449
EAN: 9781405104449
Sprache: Englisch.
Herausgegeben von Morrell M. Avram
BLACKWELL PUBL

Dezember 2003 - gebunden - 200 Seiten

Inhaltsverzeichnis

Dedication (Motrrell Michael Avram). Introduction: Resumative synthesis of contents: It is time for further renoprotection (Morrell Michael Avram). Hemoglobin predicts long-term survival in dialysis patients: A 15-year single-center longitudinal study and a correlation trend between prealbumin and hemoglobin (Morrell Michael Avram, Daniel Blaustein, Paul A. Fein, Naveen Goel, Jyotiprakas Chattopadhyay, and Neal Mittman). Prospective trials on anemia of chronic disease: the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) (Madhumathi Rao and Brian J.G. Pereira). Anemia of chronic Disease: Past, present, and future (Robert D. Toto). Chronic kidney disease and cardiovascular disease in the Medicare population (Allan J. Collins, Shuling Li, David T. Gilbertson, Jiannong Liu, Shu-Cheng Chen, adn Charles A. Herzong). Anemia as a risk factor for cardiovascular disease (Arema A. Pereira and Mark J. Sarnak). Erythropoietin should be part of congestive heart failure management (Donald S. Silverberg, Dov Wexler, Miriam Blum, Doran Schwartz, Yoram Wollman, adn Adrian Iaina). Effect of erythropoietin on exercise capacity in anemic patients with advanced heart failure (Donna M. Mancini and Chandra Kunavarapu). Relationship of bioelectrical impedance parameters to nutrition and survival in peritoneal dialysis patients (Robert Mushnick, Paul A. Fein, Neal Mittman, Naveen Goel, Jyotiprakas Chattopadhyay, and Morrell M. Avram). Treating azotemia-induced anemia with erythropoietin improves diabetic eye disease (Eli A. Friedman, Francis A. L'esperance, Jr., Clinton D. Brown, and David H. Berman). Controversies in iron management (Allen R. Missenson and Chaim Charytan). The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease (Daniel A. Blaustein, Michael H. Schwenk, Jyoti Chattopadhyay, Harinder Singh, Rachid Daoui, Radjeep Gadh, and Morrell M. Avram). Erythropoeitin dose variation in different facilities in different countries and its relationship to drug resistance (Roger N. Greenwood, Claudio Ronco, Fiorella Gastaldon, Alessandra Brendolan, Peter Homel, Len Usvyat, Lenore Bruno, Mary Carter, adn Nathan W. Levin). Malnutrition and inflammation in peritoneal dialysis patients (Paul A. Fein, Neal Mittman, Rajdeep Gadh, Jyotiprakas Chattopadhyay, Daniel blaustein, Robert Mushnick ,a nd Morrell M. Avram). Serum albumin concentration in dialysis patients: Why does it remain resistant to therapy (George A. Kaysen). Transforming growth factor beta and progression of renal disease (Phyllis August and Manikkam Suthanthiran). Obstructive nephropathy and renal fibrosis: the role of bone morphogenic protein-7 and hepatocyte growth factor (Saulo Klahr and Jeremiah Morrissey). Overview of renal bone disease: Causes of treatment failure, clinical observations, the changing pattern of bone lesions, and future therapeutic approach (Francisco lloach and Elvira Fernandez). New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure (William G. Goodman). An update on vitamin D as related to nephrology practice: 2003 (Jack W. Coburn). The impact of calcimimetics on mineral metabolism and secondary hyperparathyroidism in end-stage renal disease (Geoffrey A. Block)
Servicehotline
089 - 70 80 99 47

Mo. - Fr. 8.00 - 20.00 Uhr
Sa. 10.00 - 20.00 Uhr
Filialhotline
089 - 30 75 75 75

Mo. - Sa. 9.00 - 20.00 Uhr
Bleiben Sie in Kontakt:
Sicher & bequem bezahlen:
akzeptierte Zahlungsarten: Überweisung, offene Rechnung,
Visa, Master Card, American Express, Paypal
Zustellung durch:
* Alle Preise verstehen sich inkl. der gesetzlichen MwSt. Informationen über den Versand und anfallende Versandkosten finden Sie hier.
** Deutschsprachige eBooks und Bücher dürfen aufgrund der in Deutschland geltenden Buchpreisbindung und/oder Vorgaben von Verlagen nicht rabattiert werden. Soweit von uns deutschsprachige eBooks und Bücher günstiger angezeigt werden, wurde bei diesen kürzlich von den Verlagen der Preis gesenkt oder die Buchpreisbindung wurde für diese Titel inzwischen aufgehoben. Angaben zu Preisnachlässen beziehen sich auf den dargestellten Vergleichspreis.